Nonstructural 3/4A protease of hepatitis C virus activates epithelial growth factor-induced signal transduction by cleavage of the T-cell protein tyrosine phosphatase
- 23 January 2009
- journal article
- viral hepatitis
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 49 (6), 1810-1820
- https://doi.org/10.1002/hep.22857
Abstract
The hepatitis C virus (HCV) is a worldwide major cause of chronic liver disease with a high tendency to establish a persistent infection. To permit persistent replication of viral genomes through the cellular translation machinery without affecting host cell viability, viruses must have developed mechanisms to control cellular cascades required for sufficient viral replication, on the one hand, and to adapt viral replication to the cellular requirements on the other hand. The present study aimed to further elucidate mechanisms by which HCV targets growth factor signaling of the host cell and their implications for viral replication. The study describes a novel mechanism by which HCV influences the activation of the epithelial growth factor receptor/Akt pathway through a nonstructural (NS)3/4A‐dependent down‐regulation of the ubiquitously expressed tyrosine phosphatase T cell protein tyrosine phosphatase (TC‐PTP). NS3/4A is demonstrated to cleave TC‐PTP protease‐dependently in vitro at two cleavage sites. The in vivo relevance of this finding is supported by the fact that down‐regulation of TC‐PTP protein expression could also be demonstrated in HCV‐infected individuals and in transgenic mice with intrahepatic expression of NS3/4A. Conclusion: This down‐regulation of TC‐PTP results in an enhancement of epithelial growth factor (EGF)‐induced signal transduction and increases basal activity of Akt, which is demonstrated to be essential for the maintenance of sufficient viral replication. Hence, therapeutic targeting of NS3/4A may not only disturb viral replication by blocking the processing of the viral polyprotein but also exerts unforeseen indirect antiviral effects, further diminishing viral replication. (HEPATOLOGY 2009;49:1810–1820.)This publication has 25 references indexed in Scilit:
- Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral responseBiological Chemistry, 2008
- Involvement of PI3K in HCV‐related lymphoproliferative disordersJournal of Cellular Physiology, 2007
- Host factors involved in the replication of hepatitis C virusReviews in Medical Virology, 2007
- Replication of hepatitis C virusNature Reviews Microbiology, 2007
- The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor mediated liver diseaseGut, 2006
- Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infectionProceedings of the National Academy of Sciences of the United States of America, 2006
- Hepatitis C Virus Stimulates the Expression of Cyclooxygenase-2 via Oxidative Stress: Role of Prostaglandin E 2 in RNA ReplicationJournal of Virology, 2005
- Selective regulation of tumor necrosis factor–induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphataseNature Immunology, 2005
- The Hepatitis C Virus NS5A Protein Activates a Phosphoinositide 3-Kinase-dependent Survival Signaling CascadePublished by Elsevier BV ,2004
- Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor SignalingMolecular and Cellular Biology, 2003